ATAI
Price
$3.23
Change
+$0.44 (+15.77%)
Updated
Jul 18 closing price
Capitalization
685.22M
28 days until earnings call
QNTM
Price
$23.37
Change
+$0.86 (+3.82%)
Updated
Jul 18 closing price
Capitalization
80M
Interact to see
Advertisement

ATAI vs QNTM

Header iconATAI vs QNTM Comparison
Open Charts ATAI vs QNTMBanner chart's image
ATAI Life Sciences
Price$3.23
Change+$0.44 (+15.77%)
Volume$14.99M
Capitalization685.22M
Quantum Biopharma
Price$23.37
Change+$0.86 (+3.82%)
Volume$107.14K
Capitalization80M
ATAI vs QNTM Comparison Chart in %
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. QNTM commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and QNTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ATAI: $3.23 vs. QNTM: $23.37)
Brand notoriety: ATAI and QNTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 326% vs. QNTM: 36%
Market capitalization -- ATAI: $685.22M vs. QNTM: $80M
ATAI [@Biotechnology] is valued at $685.22M. QNTM’s [@Biotechnology] market capitalization is $80M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileQNTM’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • QNTM’s FA Score: 0 green, 5 red.
According to our system of comparison, ATAI is a better buy in the long-term than QNTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while QNTM’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 4 bearish.
  • QNTM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ATAI and QNTM are a good buy in the short-term.

Price Growth

ATAI (@Biotechnology) experienced а +23.28% price change this week, while QNTM (@Biotechnology) price change was +25.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($685M) has a higher market cap than QNTM($80M). QNTM YTD gains are higher at: 535.054 vs. ATAI (142.857). QNTM has higher annual earnings (EBITDA): -20.68M vs. ATAI (-145.09M). ATAI has more cash in the bank: 98.2M vs. QNTM (3.54M). QNTM has less debt than ATAI: QNTM (1.28M) vs ATAI (26.7M). ATAI has higher revenues than QNTM: ATAI (1.86M) vs QNTM (0).
ATAIQNTMATAI / QNTM
Capitalization685M80M856%
EBITDA-145.09M-20.68M702%
Gain YTD142.857535.05427%
P/E RatioN/AN/A-
Revenue1.86M0-
Total Cash98.2M3.54M2,775%
Total Debt26.7M1.28M2,086%
FUNDAMENTALS RATINGS
ATAI vs QNTM: Fundamental Ratings
ATAI
QNTM
OUTLOOK RATING
1..100
4786
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
90100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3534
P/E GROWTH RATING
1..100
15100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATAI's Valuation (70) in the Miscellaneous Commercial Services industry is in the same range as QNTM (75) in the null industry. This means that ATAI’s stock grew similarly to QNTM’s over the last 12 months.

ATAI's Profit vs Risk Rating (90) in the Miscellaneous Commercial Services industry is in the same range as QNTM (100) in the null industry. This means that ATAI’s stock grew similarly to QNTM’s over the last 12 months.

ATAI's SMR Rating (98) in the Miscellaneous Commercial Services industry is in the same range as QNTM (100) in the null industry. This means that ATAI’s stock grew similarly to QNTM’s over the last 12 months.

QNTM's Price Growth Rating (34) in the null industry is in the same range as ATAI (35) in the Miscellaneous Commercial Services industry. This means that QNTM’s stock grew similarly to ATAI’s over the last 12 months.

ATAI's P/E Growth Rating (15) in the Miscellaneous Commercial Services industry is significantly better than the same rating for QNTM (100) in the null industry. This means that ATAI’s stock grew significantly faster than QNTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAIQNTM
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 14 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SAMVX11.960.04
+0.34%
Virtus Ceredex Mid-Cap Value Equity A
FDSVX67.030.10
+0.15%
Fidelity Growth Discovery
AIGIX22.12-0.01
-0.05%
Alger International Opportunities I
AILLX27.75-0.05
-0.18%
Aristotle Core Equity I-2
LIONX10.07-0.03
-0.30%
Issachar N

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+15.77%
MNMD - ATAI
53%
Loosely correlated
N/A
RXRX - ATAI
47%
Loosely correlated
+5.80%
CYBN - ATAI
45%
Loosely correlated
-1.65%
SYRE - ATAI
43%
Loosely correlated
-3.55%
ABSI - ATAI
42%
Loosely correlated
+8.33%
More

QNTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNTM has been loosely correlated with HYPD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if QNTM jumps, then HYPD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNTM
1D Price
Change %
QNTM100%
+3.82%
HYPD - QNTM
35%
Loosely correlated
N/A
CPIX - QNTM
26%
Poorly correlated
-13.21%
RNA - QNTM
26%
Poorly correlated
-0.82%
ATAI - QNTM
24%
Poorly correlated
+15.77%
EBS - QNTM
23%
Poorly correlated
-4.81%
More